Journal article icon

Journal article

Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma

Abstract:
Introduction Fractional exhaled nitric oxide is a simple, non-invasive measurement of airway inflammation with minimal discomfort to the patient and with results available within a few minutes. This study aimed to evaluate the cost-effectiveness of asthma management using fractional exhaled nitric oxide monitoring in patients between 4 and 18 years of age. Methods A Markov model was used to estimate the cost-utility of asthma management using fractional exhaled nitric oxide monitoring versus asthma management without using fractional exhaled nitric oxide monitoring (standard therapy) in patients between 4 and 18 years of age. Cost data were obtained from a retrospective study on asthma from a tertiary center, in Medellin, Colombia, while probabilities of the Markov model and utilities were obtained from the systematic review of published randomized clinical trials. The analysis was carried out from a societal perspective. Results The model showed that fractional exhaled nitric oxide monitoring was associated with a lower total cost than standard therapy (US $1333 vs. US $1452 average cost per patient) and higher QALYs (0.93 vs. 0.92 average per patient). The probability that fractional exhaled nitric oxide monitoring provides a more cost-effective use of resources compared with standard therapy exceeds 99% for all willingness-to-pay thresholds. Conclusion Asthma management using fractional exhaled nitric oxide monitoring was cost-effective for treating patients between 4 and 18 years of age with mild to moderate allergic asthma. Our study suggests evidence that could be used by decision-makers to improve clinical practice guidelines, but this should be replicated in different clinical settings
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1186/s12962-021-00287-3

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-2404-6612
More by this author
Role:
Author
ORCID:
0000-0001-8944-4027
More by this author
Role:
Author
ORCID:
0000-0003-2560-6693


Publisher:
BioMed Central
Journal:
Cost Effectiveness and Resource Allocation More from this journal
Volume:
19
Issue:
1
Pages:
33-33
Article number:
33
Publication date:
2021-06-03
DOI:
EISSN:
1478-7547
ISSN:
1478-7547


Language:
English
Keywords:
Pubs id:
1490781
Local pid:
pubs:1490781
Source identifiers:
W3164233372
Deposit date:
2026-05-11
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP